Cm. Mcvicar et al., Analysis of the post-translational processing of chromogranin a in rat neuroendocrine tissue employing an N-terminal site-specific antiserum, J NEUROENDO, 13(7), 2001, pp. 588-595
Chromogranin A (CgA) is a complex prohormone expressed as a constituent of
the regulated secretory pathway of numerous neuroendocrine cells. Recent in
vestigations have demonstrated that CgA is selectively cleaved to generate
distinct peptides in different neuroendocrine tissues. This investigation e
mployed a site-specific antiserum that detects residues 98-106 rat CgA to e
xamine the amino-terminal processing of CgA to generate beta -granin and re
lated peptides in rat neuroendocrine tissues. Immunohistochemistry revealed
moderate to intense beta -granin-like immunostaining in cells scattered th
roughout the anterior pituitary, thyroid, in the islets of Langerhans and i
n the mucosa of the gastrointestinal tract. Variable intensities of immunos
taining were observed in distinct clusters of chromaffin cells. Quantitativ
ely, the highest concentration of beta -granin-like immunoreactivity was de
tected in pituitary extracts. Significantly lower concentrations were detec
ted in adrenal and thyroid glands, brain, ventral and dorsal pancreatic lob
es and gastrointestinal tissue extracts. Chromatography resolved three dist
inct beta -granin-like immunoreactants; a large CgA-like form, an intermedi
ate molecular form presumably corresponding to -granin (rat CgA(1-128)) and
small immunoreactants that coeluted with the synthetic peptide. Two beta -
granin-like immunoreactants, 21 and 22 kDa, were detected following immunob
lot analysis of pituitary extracts. This study has demonstrated that chromo
granin A is subject to distinct amino-terminal patterns of tissue-and cell-
specific processing to generate a beta -granin-like immunoreactant which is
additionally cleaved in pancreatic, fundic and colonic tissue to generate
previously unidentified peptides.